Sampling
Any samples intended to be examined for the presence of a TSE shall be collected using the methods and protocols laid down in the latest edition of the Manual of standards for diagnostic tests and vaccines of the International Office for Epizooties (IOE/OIE) (hereinafter referred to as 'the Manual'). In the absence of such methods and protocols, the samples shall be collected in a manner appropriate for the correct application of tests. The samples shall be correctly marked as to the identity of the sampled animal.
Laboratories
Any laboratory examination for TSE shall be carried out in laboratories approved for that purpose.
Methods and protocols
3.1. Laboratory testing for the presence of BSE in bovine animals
Suspect cases
Tissues from bovine animals sent for laboratory testing pursuant to the provisions of Article 12(2) shall be subject to a histopathological examination as laid down in the latest edition of the Manual, except where the material is autolysed. Where the result of the histopathological examination is inconclusive or negative or where the material is autolysed, the tissues shall be subjected to an examination by one of the other diagnostic methods laid down in the Manual (immunocytochemistry, immuno-blotting or demonstration of characteristic fibrils by electron microscopy). However, rapid tests cannot be used for this purpose.
If the result of one of the above examinations is positive, the animals shall be regarded a positive BSE case.
BSE monitoring
Tissues from bovine animals sent for laboratory testing pursuant to the provisions of Annex III, Chapter A, Section I (Monitoring in bovine animals) shall be examined by a rapid test.
When the result of the rapid test is inconclusive or positive, the tissues shall immediately be subject to confirmatory examinations in an official laboratory. The confirmatory examination shall start by a histopathological examination of the brainstem as laid down in the latest edition of the Manual, except where the material is autolysed or otherwise not suitable for examination by histopathology. Where the result of the histopathological examination is inconclusive or negative or where the material is autolysed, the tissues shall be subjected to an examination by one of the other diagnostic methods mentioned under (a).
An animal shall be regarded a positive BSE case if the result of the rapid test is positive or inconclusive, and
the result of the subsequent histopathological examination is positive, or
the result of another diagnostic method mentioned under (a) is positive.
3.2. Laboratory testing for the presence of scrapie in ovine and caprine animals
Suspect cases
Tissues from ovine and caprine animals sent for laboratory testing pursuant to the provisions of Article 12(2) shall be subject to a histopathological examination as laid down in the latest edition of the Manual, except where the material is autolysed. Where the result of the histopathological examination is inconclusive or negative or where the material is autolysed, the tissues shall be subjected to an examination by immunocytochemistry or immuno-blotting, as laid down in the Manual. However, rapid tests cannot be used for this purpose.
If the result of one of the above examinations is positive, the animal shall be regarded a positive scrapie case.
Scrapie monitoring
Tissues from ovine and caprine animals sent for laboratory testing pursuant to the provisions of Annex III, Chapter A, Section II (Monitoring in ovine and caprine animals) shall be examined by a rapid test.
When the result of the rapid test is inconclusive or positive, the brainstem shall immediately be sent to an official laboratory for confirmatory examinations by immunocytochemistry or immuno-blotting, as referred to under (a).
An animal shall be regarded a positive scrapie case if the result of the confirmatory examination is positive.
3.3. Laboratory testing for the presence of TSEs other than those referred to in points 3.1 and 3.2
The tests carried out to confirm the suspected presence of a TSE different from those referred to in points 3.1 and 3.2 shall include at least a histopathological examination of brain tissue. The competent authority may also require laboratory tests such as immunocytochemistry, immuno-blotting, demonstration of characteristic fibrils by electron microscopy or other methods designed to detect the disease associated form of the prion protein. In any case at least one other laboratory examination shall be carried out if the initial histopathological examination is negative or inconclusive. At least three different examinations shall be carried out in the event of the first appearance of the disease.
In particular, where BSE is suspected in a species other than bovine animals, samples shall be submitted for strain-typing, where possible.
Rapid tests
For the purposes of carrying out the tests in accordance with Article 5(3) and Article 6(1), the following methods shall be used as rapid tests within the meaning of this Regulation:
immuno-blotting test based on a western blotting procedure for the detection of the protease-resistant fragment PrPRes (Prionics Check test),
chemiluminescent ELISA test involving an extraction procedure and an ELISA technique, using an enhanced chemiluminescent reagent (Enfer test),
sandwich immunoassay for PrPRes carried out following denaturation and concentration steps (Bio-Rad Platelia test).
Alternative tests
(To be defined)"